Trials / Conditions / Pulmonary Neoplasm

Pulmonary Neoplasm

14 registered clinical trials studyying Pulmonary Neoplasm — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Impact of Different Lung Isolation Devices on Pharyngolaryngeal Injuries After Pulmonary Resection NCT07117539	Tingting Li	N/A
Recruiting	Rarecells Molecular Biomarkers for Early Detection of Lung Cancer NCT06546007	Rarecells Diagnostics SAS	—
Recruiting	Precision Lung Cancer Survivorship Care Intervention NCT05857995	Jerod L Stapleton, PhD	N/A
Recruiting	The Natural History and Biological Study of Pulmonary Recurrent Respiratory Papillomatosis (pRRP) NCT06412172	Massachusetts General Hospital	—
Recruiting	Erector Spinae Block for Thoracic Surgery NCT05521789	George Washington University	Phase 4
Unknown	Effect of Muscle and Skin Fixation of Thoracic Drainage Tube on Postoperative Pain NCT05202249	Daping Hospital and the Research Institute of Surgery of the Third Military Medical University	N/A
Active Not Recruiting	Safety and Feasibility of Surgery After Conversion Therapy for Locally Advanced and Advanced NSCLC NCT04945928	Ruijin Hospital	N/A
Unknown	ENB Vs. Conventional Bronchoscopy With Fluoroscopy for Safe and Effective Biopsy of Pulmonary Lesions NCT04447482	Shanghai Youhe Medical Technology Co., Ltd.	N/A
Unknown	Modified Versus Traditional Thoracic Drainage After Thoracoscopic Surgery NCT04309955	Daping Hospital and the Research Institute of Surgery of the Third Military Medical University	N/A
Terminated	FGFR Inhibitor in FGFR Dysregulated Cancer NCT03827850	Lung Cancer Group Cologne	Phase 2
Completed	Robot-assisted vs VATS Lobectomy for NSCLC NCT03134534	Ruijin Hospital	N/A
Unknown	Effect of Pulmonary Rehabilitation on Perioperative Outcomes in Smoker Patients With Lung Cancer NCT03010033	Ruijin Hospital	N/A
Completed	Could the Stroke Volume Variation Predict a Fluid Responsiveness in Thoracotomy? NCT02331056	Samsung Medical Center	—
Completed	Trial of Pre-operative Chemoradiotherapy Followed by Surgical Resection in Pancoast Tumors (JCOG 9806) NCT00128037	Japan Clinical Oncology Group	Phase 2